HCV - Tarvacin(TM) Anti-Viral Hepatitis C Clinical Program in ...

Tarvacin(TM) Anti-Viral Hepatitis C Clinical Program in ...
RxPG NEWS, CA - Jan 18, 2006By Peregrine Pharmaceuticals, Inc., Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM), a biopharmaceutical company with a portfolio ...

Peregrine Announces Completion of Planned Patient Enrollment and ...
Yahoo! News (press release) - Feb 15, 2006TUSTIN, Calif., Feb. 15 /PRNewswire-FirstCall/ -- Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM - News), a biopharmaceutical company ...

Peregrine Announces Acceleration of Its Tarvacin(TM) Anti-Viral ...
PR Newswire (press release), NY - Jan 18, 2006- Patient Enrollment and Dosing in Initial Phase I Trial Now Scheduled for Completion in February - - Preliminary Phase I Safety Data to Be Presented at 'Viral ...

Peregrine Announces Acceleration of Its Tarvacin(TM) Anti-Viral ...
Biotech Intelligence (press release), France - Jan 18, 2006TUSTIN, Calif., Jan. 18 /PRNewswire-FirstCall/ -- Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHM), a biopharmaceutical company with ...